Fate Therapeutics Inc. (FATE)
NASDAQ · Healthcare
Fate Therapeutics Inc. Long Term Debt 2011–2025
Fate Therapeutics Inc. annual long term debt history from 2012 to 2018. Long term debt refers to financial obligations that are due more than one year in the future.
- Fate Therapeutics Inc. long term debt as of December 31, 2018: 18.5M, a 4.34% decrease year-over-year.
- Fate Therapeutics Inc. long term debt for 2018 were 18.5M, a 4.34% decrease from 2017.
- Fate Therapeutics Inc. long term debt for 2017 were 19.3M, a 50.79% increase from 2016.
- Fate Therapeutics Inc. long term debt for 2016 were 12.8M, a 40.60% decrease from 2015.
- Fate Therapeutics Inc. long term debt for 2015 were 21.6M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Fate Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2018 | $18 |
| 2017 | $19 |
| 2016 | $13 |
| 2015 | $22 |
| 2013 | $2 |
| 2012 | $4 |
Fate Therapeutics Inc. Long Term Debt — FAQ
Fate Therapeutics Inc. (FATE) long term debt over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see FATE's long term debt history?
The chart and table above show Fate Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.